Search results
Novavax Stock Just Tripled. Is It Too Late to Buy?
Motley Fool via Yahoo Finance· 1 week agoThe company also announced positive clinical-trial data for its combined flu/coronavirus vaccine candidate and aims to launch a phase 3 trial< ...
3 Things You Need to Know If You Buy Novavax Today | The Motley Fool
The Motley Fool· 3 days agoNovavax (NVAX 5.30%) stock has both soared and plummeted at times in recent years. Investors...
Is Novavax Stock A Buy After Nearly Tripling On $1.3 Billion Sanofi Deal?
Investor's Business Daily· 2 weeks agoNovavax stock isn't a buy. Savvy investors are encouraged to buy a stock after it breaks out of a...
Could Novavax Become the Next Moderna?
Motley Fool via Yahoo Finance· 1 week agoNovavax entered the coronavirus vaccine market late, missing out on the biggest revenue opportunity. This disappointed investors, and the stock plummeted...
This Stock Just More Than Doubled in 1 Day: Is It a Buy?
Motley Fool via Yahoo Finance· 6 days agoNovavax is still developing a COVID-19/flu combination vaccine. It plans to start a phase 3 trial in...
Is Novavax Stock a Buy?
Motley Fool via Yahoo Finance· 7 days agoNovavax is safe for now -- but what about in the long run? Novavax isn't in imminent danger, which is good news. But that doesn't mean ...
The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers
Zacks via Yahoo Finance· 1 week agoBMY also announced that the late-stage CheckMate -73L trial did not meet its primary endpoint of...
The Next Novavax? 3 Biopharma Stocks to Buy Before They Boom
InvestorPlace· 2 days agoNovavax (NASDAQ:NVAX) stock was among the laggards in the race for the vaccine against COVID-19....
Novavax Starts A New Chapter, Turning The Page On Financial Uncertainty
RTT News· 2 weeks agoJust when the Covid-vaccine maker Novavax Inc.'s (NVAX) future as a going concern seemed uncertain, a remarkable turnaround has unfolded, thanks to the ...
Moderna and Pfizer In Talks With U.S. To Make a Bird Flu Vaccine
Barrons.com· 2 days agoShares of Novavax which makes a Covid-19 vaccine, were up 6.3%. Even vaccine stalwarts like GSK and...